BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 1565462)

  • 41. Hematopoietic development of vav-/- mouse embryonic stem cells.
    Zhang R; Tsai FY; Orkin SH
    Proc Natl Acad Sci U S A; 1994 Dec; 91(26):12755-9. PubMed ID: 7809116
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Expression of vav proto-oncogene by nonhematopoietic trophoblast cells at the human uteroplacental interface.
    Higuchi T; Kanzaki H; Fujimoto M; Hatayama H; Watanabe H; Fukumoto M; Kaneko Y; Higashitsuji H; Kishishita M; Mori T
    Biol Reprod; 1995 Oct; 53(4):840-6. PubMed ID: 8547479
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Genomic organization and regulation of the vav proto-oncogene.
    Denkinger DJ; Borges CR; Butler CL; Cushman AM; Kawahara RS
    Biochim Biophys Acta; 2000 Apr; 1491(1-3):253-62. PubMed ID: 10760587
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Expression cloning of lfc, a novel oncogene with structural similarities to guanine nucleotide exchange factors and to the regulatory region of protein kinase C.
    Whitehead I; Kirk H; Tognon C; Trigo-Gonzalez G; Kay R
    J Biol Chem; 1995 Aug; 270(31):18388-95. PubMed ID: 7629163
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Control of intramolecular interactions between the pleckstrin homology and Dbl homology domains of Vav and Sos1 regulates Rac binding.
    Das B; Shu X; Day GJ; Han J; Krishna UM; Falck JR; Broek D
    J Biol Chem; 2000 May; 275(20):15074-81. PubMed ID: 10748082
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Thrombin receptor activation and integrin engagement stimulate tyrosine phosphorylation of the proto-oncogene product, p95vav, in platelets.
    Cichowski K; Brugge JS; Brass LF
    J Biol Chem; 1996 Mar; 271(13):7544-50. PubMed ID: 8631786
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Structure and function of vav.
    Romero F; Fischer S
    Cell Signal; 1996 Dec; 8(8):545-53. PubMed ID: 9115846
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inhibition of hematopoietic development from embryonic stem cells by antisense vav RNA.
    Wulf GM; Adra CN; Lim B
    EMBO J; 1993 Dec; 12(13):5065-74. PubMed ID: 8262049
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Interferon-alpha signaling promotes nucleus-to-cytoplasmic redistribution of p95Vav, and formation of a multisubunit complex involving Vav, Ku80, and Tyk2.
    Adam L; Bandyopadhyay D; Kumar R
    Biochem Biophys Res Commun; 2000 Jan; 267(3):692-6. PubMed ID: 10673353
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Structural basis for relief of autoinhibition of the Dbl homology domain of proto-oncogene Vav by tyrosine phosphorylation.
    Aghazadeh B; Lowry WE; Huang XY; Rosen MK
    Cell; 2000 Sep; 102(5):625-33. PubMed ID: 11007481
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Loss of the amino-terminal helix-loop-helix domain of the vav proto-oncogene activates its transforming potential.
    Katzav S; Cleveland JL; Heslop HE; Pulido D
    Mol Cell Biol; 1991 Apr; 11(4):1912-20. PubMed ID: 2005887
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The VAV family of signal transduction molecules.
    Bustelo XR
    Crit Rev Oncog; 1996; 7(1-2):65-88. PubMed ID: 9109498
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Critical role of the pleckstrin homology and cysteine-rich domains in Vav signaling and transforming activity.
    Palmby TR; Abe K; Der CJ
    J Biol Chem; 2002 Oct; 277(42):39350-9. PubMed ID: 12177050
    [TBL] [Abstract][Full Text] [Related]  

  • 54. vav, a novel human oncogene derived from a locus ubiquitously expressed in hematopoietic cells.
    Katzav S; Martin-Zanca D; Barbacid M
    EMBO J; 1989 Aug; 8(8):2283-90. PubMed ID: 2477241
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Association of PI 3-K with tyrosine phosphorylated Vav is essential for its activity in neutrophil-like maturation of myeloid cells.
    Bertagnolo V; Brugnoli F; Marchisio M; Celeghini C; Carini C; Capitani S
    Cell Signal; 2004 Apr; 16(4):423-33. PubMed ID: 14709332
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Regulation of Vav proteins by intramolecular events.
    Bustelo XR
    Front Biosci; 2002 Jan; 7():d24-30. PubMed ID: 11779690
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Phylogenetic conservation of the regulatory and functional properties of the Vav oncoprotein family.
    Couceiro JR; Martín-Bermudo MD; Bustelo XR
    Exp Cell Res; 2005 Aug; 308(2):364-80. PubMed ID: 15950967
    [TBL] [Abstract][Full Text] [Related]  

  • 58. N-terminally truncated Vav induces the formation of depolymerization-resistant actin filaments in NIH 3T3 cells.
    Kranewitter WJ; Gimona M
    FEBS Lett; 1999 Jul; 455(1-2):123-9. PubMed ID: 10428485
    [TBL] [Abstract][Full Text] [Related]  

  • 59. PU.1 regulates the expression of the vav proto-oncogene.
    Denkinger DJ; Lambrecht TQ; Cushman-Vokoun AM; Kawahara RS
    J Cell Biochem; 2002; 84(4):772-83. PubMed ID: 11835402
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Fission yeast cdc24(+) encodes a novel replication factor required for chromosome integrity.
    Gould KL; Burns CG; Feoktistova A; Hu CP; Pasion SG; Forsburg SL
    Genetics; 1998 Jul; 149(3):1221-33. PubMed ID: 9649516
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.